Table 1 Baseline characteristics of randomized participants in the SELEBLAT trial
Variable | Â | Total 100 | |
|---|---|---|---|
Gender [N (%)] | Male [N (%)] | 83 | (83) |
| Â | Female | 17 | (17) |
Age | ≤ 50 yrs. [N (%)] | 2 | (2) |
| Â | 51-60 [N (%)] | 17 | (17) |
| Â | 61-70 [N (%)] | 34 | (34) |
| Â | 71-80 [N (%)] | 36 | (36) |
| Â | > 80 [N (%)] | 11 | (11) |
| Â | Years [mean, (SD)] | 68 | (9) |
Language [N (%)] | Dutch | 87 | (87) |
| Â | French | 13 | (13) |
Primary | Primary | 61 | (60) |
Tumour [N (%)] | Recurrent | 35 | (35) |
| Â | Unknown | 5 | (5) |
Tumour | G1 | 31 | (30) |
Grade [N (%)] | G2 | 35 | (34) |
| Â | G3 | 33 | (32) |
| Â | Unknown | 4 | (4) |
Tumour | pTa | 60 | (58) |
Stage [N (%)] | pT1 | 31 | (30) |
| Â | Cis | 5 | (5) |
| Â | Unknown | 7 | (7) |
Tumour | Papillary | 121 | (79) |
Type [N (%)] | Cis | 29 | (19) |
| Â | Unknown | 3 | (2) |
Tumour | < 1 cm | 59 | (38) |
Size [N (%)] | ≥1 and ≤ 3 | 56 | (37) |
| Â | > 3 cm | 38 | (25) |
Tumour | Solitary | 59 | (60) |
Number [N (%)] | 2 or more | 36 | (36) |
| Â | Unknown | 4 | (4) |
Selenium | ng/mL [mean, (SD)] | 84.8 | (18.5) |